Bod Australia (ASX: BDA) has agreed to supply its medicinal cannabis extracts to speciality pharmaceutical company iX Biopharma (SGX: 42C) for use in clinical trials.
Bod’s cannabis oils and raw materials will be used in iX Biopharma’s WaferiX product which is a small wafer that dissolves under a person’s tongue and releases any active compounds for rapid absorption.
iX Biopharma’s patented WaferiX does not have an aftertaste or residue. Bod’s medicinal cannabis extracts will be manufactured in the WaferiX and undergo phase 1 clinical trials.
“We are pleased to have